Paul Harmatz
UCSF Benioff Children's Hospital · 563 works · 14,592 citations · h-index 65
Top works
- A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
- Successful Treatment of Primary Amebic Meningoencephalitis
- Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
- Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome)
- Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
- Direct Comparison of Measures of Endurance, Mobility, and Joint Function During Enzyme-Replacement Therapy of Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome): Results After 48 Weeks in a Phase 2 Open-Label Clinical Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase
- Management Guidelines for Mucopolysaccharidosis VI
- Mucopolysaccharidosis VI
- Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management
- Oxidative stress and inflammation in iron‐overloaded patients with β‐thalassaemia or sickle cell disease
- Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy
- Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase
- Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
- Multidisciplinary Management of Hunter Syndrome
- Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
- Increased prevalence of iron‐overload associated endocrinopathy in thalassaemia versus sickle‐cell disease
- C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia
- Efficacy of Sapropterin Dihydrochloride in Increasing Phenylalanine Tolerance in Children with Phenylketonuria: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi‐center study of iron overload
- Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial